Otsuka Pharmaceutical Co., Ltd.
Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd., explained in plain language.
Pharmaceutical company developing treatments for mental health and other diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New eczema foam shows promise for kids in Late-Stage trial
Disease control Not yet recruitingThis Phase 3 trial tests a medicated foam called OPA-15406 (difamilast) for atopic dermatitis (eczema) in children aged 2 and older, and infants under 2. About 198 participants will apply the foam twice daily for 8 weeks. The main goal is to see if the foam clears or nearly clear…
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New eczema foam shows promise in Late-Stage trial
Disease control Not yet recruitingThis Phase 3 trial tests a medicated foam called OPA-15406 (difamilast) for adults with atopic dermatitis, a common skin condition causing red, itchy rashes. About 156 participants will apply the foam or a placebo twice daily for 4 weeks. The goal is to see if the foam clears or …
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC